Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada

Launched by PERIPHARM · Jun 16, 2025

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• • Patient Inclusion Criteria
• • 1. ≥18 years old
• • 2. Patients with PROC who received \>1 prior line of therapy identified through a screening survey. PROC will be defined as recurrence less than 6 months after last platinum chemotherapy (i.e. carboplatin or cisplatin)
• • 3. Ability to read and understand French or English
• • 4. Signature of ICF
• • Patients Exclusion Criteria
• 1. Patients with PSOC, defined as those who:
• • 1. Have not progressed within less than 6 months after completion of platinum-based chemotherapy or;
• • 2. Are still on platinum chemotherapy or;
• • 3. Receive maintenance therapy.
• • 2. Patients with platinum-refractory ovarian cancer, defined as not responding or disease progressing during therapy or within three months after the last dose
• Caregivers Inclusion Criteria:
• • 1. ≥18 years old
• • 2. Current caregiver of a patient with PROC (see definition to be used above) who received \>1 prior line of therapy identified through a screening survey.
• • 3. Ability to read and understand French or English
• • 4. Signature of ICF.
• Caregivers Exclusion Criteria:
• • 1. Caregivers of patients with PSOC (see definition above)
• • 2. Caregivers of PROC patients who have passed away
• • 3. Caregivers of platinum-refractory patients (see definition above)